NDC 70518-4324 – Medroxyprogesterone acetate
Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Intramuscular
Product NDC70518-4324
Product details
- Brand name
- Medroxyprogesterone acetate
- Generic name
- Medroxyprogesterone acetate
- Labeler
- REMEDYREPACK INC.
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- ANDA · ANDA215397
- Marketed since
- April 1, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Progestin
Active ingredients
- Medroxyprogesterone Acetate 150 mg/mL
Uses, dosage, side effects and warnings for Medroxyprogesterone acetate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70518-4324-0 | 1 SYRINGE, GLASS in 1 CARTON (70518-4324-0) / 1 mL in 1 SYRINGE, GLASS | Apr 1, 2025 |
Other Medroxyprogesterone acetate products
- 50090-5619 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · A-S Medication Solutions
- 50090-5925 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · A-S Medication Solutions
- 70121-1480 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Amneal Pharmaceuticals LLC
- 70121-1467 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Amneal Pharmaceuticals LLC
- 60219-1467 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Amneal Pharmaceuticals NY LLC
- 55150-329 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Eugia US LLC
- 55150-330 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Eugia US LLC
- 67457-887 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Mylan Institutional LLC
- 66993-370 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Prasco Laboratories
- 66993-371 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Prasco Laboratories
- 62756-090 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Sun Pharmaceutical Industries, Inc.
- 62756-091 Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Sun Pharmaceutical Industries, Inc.